Musculoskeletal Aspects of Haemophilia

[1]  P. Giangrande,et al.  Increased bleeding associated with protease inhibitor therapy in HIV‐positive patients with bleeding disorders , 1999, British journal of haematology.

[2]  C. Kessler,et al.  Vaccines for prevention of viral hepatitis , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  C. Kessler,et al.  Continuous infusion therapy in haemophilia , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[4]  P. Mannucci.  Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. , 1997, Blood.

[5]  C. Hay,et al.  Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors' Organisation Inhibitor Working Party. , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[6]  K. Rickard.  Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia , 1995, Haemophilia : the official journal of the World Federation of Hemophilia.

[7]  E. Lawlor,et al.  Investigation of an Outbreak of Hepatitis A in Irish Haemophilia A Patients , 1994, Vox sanguinis.

[8]  M. Hilgartner,et al.  Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII , 1993, The Lancet.

[9]  E. Berntorp,et al.  Treatment of Patients with Factor VIII and IX Inhibitors , 1993, Thrombosis and Haemostasis.

[10]  S. Arkin,et al.  Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group. , 1993, The New England journal of medicine.

[11]  S. Schulman,et al.  Adjusted dose continuous infusion of factor VIII in patients with haemophilia A , 1992, British journal of haematology.

[12]  E. Santagostino,et al.  Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody. , 1991, Haemostasis.

[13]  J. Levy,et al.  AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations. , 1986, Blood.

[14]  P. Mannucci,et al.  TRANSMISSION OF NON-A, NON-B HEPATITIS BY HEAT-TREATED FACTOR VIII CONCENTRATE , 1985, The Lancet.

[15]  P. Karayiannis,et al.  Acute fulminant non-A, non-B hepatitis leading to chronic active hepatitis after treatment with cryoprecipitate. , 1985, Gut.

[16]  R. Batey,et al.  HEPATITIS AND HAEMOPHILIA THERAPY IN AUSTRALIA , 1982, The Lancet.